OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value Creation Completion of Tedopi’s phase 3 in Non-Small Cell Lung Cancer One or two new rare/specialty ...

US President Donald Trump’s emissaries to the Kremlin may have been spinning their wheels during talks last week in Moscow on ...

Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader in pharmaceutical manufacturing, and Corealis Pharma Inc ...

The Northern States Governors’ Forum (NSGF) has appointed Mr. Ezekiel Gomos, OFR, as the Director-General of its Secretariat, ...

Jan Suraj founder and political strategist Prashant Kishor is expected to visit Jammu and Kashmir in February next year to ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development and manufacturing, ...

POTOMAC, MARYLAND / ACCESS Newswire / December 9, 2025 / IGC Pharma, Inc. ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) to develop innovative ...

The Federal Government has said it will not initiate any new projects in the 2026 budget. It directed Ministries, Departments ...

The need for coalitions is an admission that the US isn’t powerful enough anymore. But the problem is obvious. How do you ...

AVIM Therapy for the Treatment of Hypertensive Heart Disease, presented by Avi Fischer, M.D., Senior Vice President of Medical Affairs and Innovation, Orchestra Biomed (December 8, 2025; 15:12 IST / ...

Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...